{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Knoxville",
      "address_1": "6216 Highland Place Way Ste 101-A",
      "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility",
      "address_2": "",
      "product_quantity": "66 ml total volume",
      "code_info": "All lots distributed between November 2014 and May 2015;  04062015@12, 7/5/2015; 04062015@35, 7/5/2015; 05012015@50, 7/30/2015",
      "center_classification_date": "20150915",
      "distribution_pattern": "Nationwide",
      "state": "TN",
      "product_description": "Fentanyl 20,000 mcg/ml + Bupivacaine 30 mg/ml + Clonidine 1,300 mcg/ml + Baclofen 350 mcg/ml Intrathecal Solution, The Compounding Pharmacy of America Knoxville, TN",
      "report_date": "20150923",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "The Compounding Pharmacy of America",
      "recall_number": "D-1483-2015",
      "initial_firm_notification": "Telephone",
      "product_type": "Drugs",
      "event_id": "71371",
      "termination_date": "20160210",
      "more_code_info": "",
      "recall_initiation_date": "20150602",
      "postal_code": "37919-4068",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}